A Study of Experimental Combination of CPX-351 and Gemtuzumab Ozogamicin For Relapsed Acute Myeloid Leukemia
Acute Myelogenous Leukemia AML, Leukemia Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Cytarabine Daunorubicin Gemtuzumab Gemtuzumab Ozogamicin Liposome-encapsulated Daunorubicin-Cytarabine
Lead Scientist at UC Davis
- Brian A. Jonas
Assistant Professor, Hematology and Oncology. Authored (or co-authored) 46 research publications.